Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2006

View Archived Issues

GYKI-16084 improves symptoms in benign prostatic hyperplasia

Phase I study data support fixed dosing of ABT-751 in cancer patients

Effect of sildenafil on peak systolic velocity a mechanism of erection improvement

Advanced Cell Technology announces timetables for IND filings in key therapeutic programs

Advaxis reports update of Listeria-based vaccines

Hemispherx Biopharma to conduct influenza vaccine/immunopotentiation phase II clinical trial

PhytoMedical Technologies' BDC-O3 holds potential for atherosclerosis

Patient enrollment complete for X-Cell Medical's ETHOS II estradiol-eluting stent trial

Marshall Edwards achieves SPA for pivotal trial of phenoxodiol

Patient enrollment complete in phase III trial of telavancin for cSSSI

More positive data reported for Nymox's BPH drug candidate

BioMS Medical receives approval to begin phase II RRMS trial

Phase II trial of Manhattan Pharmaceutical's obesity drug candidate cleared in Switzerland

Shire provides update on Elaprase's registration process

Migenix receives approval in Canada to begin phase II trial for HCV

Intercept Pharmaceuticals' INT-747 well tolerated in phase Ia study

Lexiva has comparable activity to the preferred HIV protease inhibitor Kaletra

TC-1734 reaches endpoints in age-associated memory impairment phase II trials

Novel antiinfective agents disclosed in recent patent literature

Novel treatment options for metabolic disorders described in recent patents

FDA approves Azilect for Parkinson's disease

Promising camptothecin derivatives developed at Bristol-Meyers Squibb

Actilon granted fast track designation in U.S. as HCV therapy

FDA committee unanimously supports efficacy of Gardasil clinical data

Antisense oligomers effective against different strains of the influenza A virus in vitro

Novel triple reuptake inhibitor shows antidepressant activity in animal models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...